The Future of Technology is written in DNA
Investors & Partners
Since it’s early days, Ribbon Biolabs has been supported by partners who share our vision and believe in the potential of our technology and the capability of our team.
Invest in the future of biotech
Synthetic biology is one of the most rapidly growing markets and has disruptive potential for many industries. The major bottleneck for its advance is the availability of synthetic DNA. Ribbon Biolabs’ platform for automated high-throughput production of long DNA will help to overcome this impediment.